AAAAAA
Results: 1-25/129
Authors:
ZHANG JR
VRECKO K
NADLINGER K
TOMIC DS
BIRKMAYER GD
REIBNEGGER G
Citation: Jr. Zhang et al., THE REDUCED COENZYME NICOTINAMIDE ADENINE-DINUCLEOTIDE (NADH) REPAIRSDNA-DAMAGE OF PC12 CELLS INDUCED BY DOXORUBICIN, Journal of tumor marker oncology, 13(4), 1998, pp. 5-17
Authors:
HARBECK N
GRAEFF H
HOFLER H
BRUNNER N
SCHMITT M
Citation: N. Harbeck et al., PLASMINOGEN-ACTIVATOR SYSTEM IN BREAST-CANCER TISSUE AND BLOOD - CLINICAL RELEVANCE AND METHODOLOGICAL CONSIDERATIONS, Journal of tumor marker oncology, 13(4), 1998, pp. 19-35
Authors:
NAIDU R
YADAV M
NAIR S
KUTTY MK
Citation: R. Naidu et al., IMMUNOHISTOCHEMICAL ANALYSIS OF CATHEPSIN-D EXPRESSION IN PRIMARY BREAST CARCINOMAS, Journal of tumor marker oncology, 13(4), 1998, pp. 37-47
Authors:
SADAVA D
HEIDEL K
MCMURTRAY A
SCANLON K
Citation: D. Sadava et al., NEURON-SPECIFIC ENOLASE AND THYMIDINE KINASE - MARKERS FOR MULTIPLE-DRUG RESISTANCE AND ITS REVERSAL IN HUMAN SMALL-CELL LUNG-CANCER CELLS, Journal of tumor marker oncology, 13(4), 1998, pp. 49-52
Authors:
ANCANS J
RUPAIS A
ENGELE L
Citation: J. Ancans et al., ANTIGENS ASSOCIATED WITH PRIMARY CUTANEOUS MELANOMA PROGRESSION, Journal of tumor marker oncology, 13(4), 1998, pp. 53-56
Authors:
TAFEIT E
ESTELBERGER W
LIEBMANN PM
REIBNEGGER G
Citation: E. Tafeit et al., BIORHYTHMS AND THEIR EVALUATION WITH PERIODIC REGRESSION-ANALYSIS - ASPREADSHEET APPLICATION, Journal of tumor marker oncology, 13(4), 1998, pp. 57-64
Authors:
ZHANG JR
VRECKO K
NADLINGER K
STORGA D
BIRKMAYER GD
REIBNEGGER G
Citation: Jr. Zhang et al., THE REDUCED COENZYME NICOTINAMIDE ADENINE-DINUCLEOTIDE (NADH) RESCUESPC12 CELLS FROM APOPTOSIS, Journal of tumor marker oncology, 13(3), 1998, pp. 11-24
Authors:
MASLAK P
Citation: P. Maslak, IMMUNOPHENOTYPIC ANALYSIS IN HEMATOLOGIC ONCOLOGY, Journal of tumor marker oncology, 13(3), 1998, pp. 25-34
Authors:
PLEBANI M
BASSO D
FOGAR P
Citation: M. Plebani et al., PANCREATIC-CANCER - BIOCHEMICAL INSIGHTS IN PATHOBIOLOGY AND DIAGNOSIS, Journal of tumor marker oncology, 13(3), 1998, pp. 35-44
Authors:
SAIP P
YASASEVER V
TENEKECI N
AYDINER A
INANC S
ONAT H
DISCI R
TOPUZ E
Citation: P. Saip et al., PREDICTION OF RADIOLOGICAL RESPONSE OF BONE METASTASES TO THERAPY BY BIOCHEMICAL MARKER MONITORING IN PATIENTS WITH BREAST-CANCER - A PRELIMINARY-STUDY, Journal of tumor marker oncology, 13(3), 1998, pp. 45-52
Authors:
ENGARAS B
KEWENTER J
WEDEL H
HAFSTROM L
Citation: B. Engaras et al., EFFECTS OF SURGERY ON SERUM LEVELS OF CEA, CA-50 AND CA-242 IN INDIVIDUALS WITHOUT MALIGNANT DISEASE FOLLOWED FOR 12 MONTHS, Journal of tumor marker oncology, 13(3), 1998, pp. 53-59
Authors:
ILIJAS M
KAPITANOVIC S
SARCEVIC B
PAVELIC K
PAVELIC ZP
KURJAK A
PAVELIC J
Citation: M. Ilijas et al., GENE NM23-H1 - POSSIBLE PROGNOSTIC FACTOR FOR INVASIVE SQUAMOUS-CELL CARCINOMA OF CERVIX UTERI, Journal of tumor marker oncology, 13(3), 1998, pp. 61-68
Citation: ABSTRACTS (ORAL PRESENTATIONS) FROM THE 15TH INTERNATIONAL-CONFERENCEON HUMAN TUMOR-MARKERS, Journal of tumor marker oncology, 13(2), 1998, pp. 24-47
Citation: ABSTRACTS (POSTER PRESENTATIONS) FROM THE 15TH INTERNATIONAL-CONFERENCE ON HUMAN TUMOR-MARKERS, Journal of tumor marker oncology, 13(2), 1998, pp. 50-67
Authors:
KREUTZ FT
SURESH MR
Citation: Ft. Kreutz et Mr. Suresh, DEVELOPMENT OF A NEW 2ND-GENERATION HETEROLOGOUS DOUBLE-DETERMINANT BISPECIFIC ANTIBODY-BASED CA125 IMMUNOASSAY, Journal of tumor marker oncology, 13(2), 1998, pp. 69-77
Authors:
BYRIALSEN A
VONEYBEN FE
KRISTIANSEN K
Citation: A. Byrialsen et al., CARCINOMA IN-SITU OF THE TESTIS AND SEMINOMA EXPRESS A HIGH-LEVEL OF LACTATE-DEHYDROGENASE (LD) SUBUNIT-B BUT NO LD SUBUNIT-C, Journal of tumor marker oncology, 13(2), 1998, pp. 79-86
Authors:
NISMAN B
LAFAIR J
LYASS O
DRANITZKIELHALEL M
BARAK V
Citation: B. Nisman et al., SERUM LEVELS OF CEA, SCC, TPS AND CYFRA-21-1 IN HEMODIALYSIS-PATIENTS, Journal of tumor marker oncology, 13(2), 1998, pp. 87-93
Authors:
WANG LQ
YU YZ
SELL S
Citation: Lq. Wang et al., P53 AND PCNA AS DIFFERENTIATION MARKERS OF HEPATOCELLULAR CARCINOMAS, Journal of tumor marker oncology, 13(1), 1998, pp. 5-13
Authors:
SHALITIN C
VALANSI C
ADMON A
MOSKOVITZ B
SEGAL R
EPELBAUM R
NATIV O
Citation: C. Shalitin et al., ELEVATED LEVELS OF HAPTOGLOBIN-RELATED PROTEIN IN SERA OF CANCER-PATIENTS, Journal of tumor marker oncology, 13(1), 1998, pp. 15-25
Authors:
RON IG
DALE A
TIROSH R
DEUTSCH M
Citation: Ig. Ron et al., THE POTENTIAL OF NEW SCREENING-TESTS FOR COLORECTAL-CANCER TO ENHANCEPATIENT ACCEPTABILITY, Journal of tumor marker oncology, 13(1), 1998, pp. 27-32
Authors:
NISMAN B
LAFAIR J
LYASS O
DRANITZKIELHALEL M
BARAK V
Citation: B. Nisman et al., SERUM LEVELS OF CEA, SCC, TPS AND CYFRA-21-1 IN HEMODIALYSIS-PATIENTS, Journal of tumor marker oncology, 13(1), 1998, pp. 33-39
Authors:
MERMERSHTAIN W
SEBBAG G
ARIAD S
COHEN Y
Citation: W. Mermershtain et al., EXTREMELY ELEVATED CA-19-9 SERUM LEVEL IN A PATIENT WITH ACUTE BILIARY OBSTRUCTION AND CHRONIC CHOLECYSTITIS, Journal of tumor marker oncology, 13(1), 1998, pp. 41-42
Authors:
KHINE M
KLAVINS JV
Citation: M. Khine et Jv. Klavins, USING AFP TO DETECT FETAL ABNORMALITIES, Journal of tumor marker oncology, 13(1), 1998, pp. 43-51
Citation: ANDERS,FRITZ, THE AWARDEE OF THE 1997-PRINCE-HITACHI-PRIZE-FOR-COMPARATIVE-ONCOLOGY, Journal of tumor marker oncology, 12(4), 1997, pp. 5-7
Authors:
BIAVA PM
CARLUCCIO A
Citation: Pm. Biava et A. Carluccio, ACTIVATION OF ANTIONCOGENE P53 PRODUCED BY EMBRYONIC EXTRACTS IN IN-VITRO TUMOR-CELLS, Journal of tumor marker oncology, 12(4), 1997, pp. 9-15